Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 15-16/2014

01.08.2014 | original article

The effect of growth hormone replacement therapy on the morphological and functional changes in the left ventricle in patients with adult-onset growth hormone deficiency

verfasst von: MD, PhD Anton Dlesk, MD, PhD Assoc. Prof. Gabriel Kamenský, MD, PhD Prof. Ivica Lazúrová, MD, PhD Martin Kužma, MD, PhD Prof. Juraj Payer

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 15-16/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Objective

The aim of the study was to evaluate the effect of growth hormone (GH) replacement therapy on the morphological and functional changes in the left ventricle (LV) in patients with GH deficiency (GHD).

Methods

Patients with adult-onset GHD were treated with GH. Transthoracic echocardiography was performed at baseline and after 6 and 12 months of the treatment. Interventricular septal thickness (IVST), posterior wall thickness (PWT), left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic volume (LVEDV), left ventricular mass (LVM), stroke volume (SV) and left ventricular ejection fraction (LVEF) were evaluated at echocardiography, and the values at respective time points were compared by a paired t-test. In addition, a gender-stratified analysis was performed.

Results

A total of 45 patients (21 men, 24 women; age: 19–61 years) with GHD were included. At 6 months, only increased PWT (+ 0.2 mm; P = 0.044) was significantly changed compared with baseline. At 12 months of the replacement therapy, statistically significant increase in LVM (+ 8.6 g; P = 0.035) and improvement of LVEF (+ 1.4 %; P = 0.005) were seen.
In men, significantly higher values of IVST, PWT, LVEDD, LVEDV, SV and LVM were found at 12 months of follow-up, while no such effect was observed in women.

Conclusion

A mild increase in LVM and improvement of LVEF accompanies long-term GH replacement therapy. The effect on LV morphology is more pronounced in men than in women.
Literatur
1.
Zurück zum Zitat Cittadini A, Ishiguro Y, Strömer H, et al. Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca 2+ through a wortmannin-sensitive pathway studies in rat and ferret isolated muscles. Circ Res.1998;83:50–9. PubMedCrossRef Cittadini A, Ishiguro Y, Strömer H, et al. Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca 2+ through a wortmannin-sensitive pathway studies in rat and ferret isolated muscles. Circ Res.1998;83:50–9. PubMedCrossRef
2.
Zurück zum Zitat Freestone NS, Ribaric S, Mason WT. The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol Cell Biochem. 1996;163:223–9. PubMedCrossRef Freestone NS, Ribaric S, Mason WT. The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol Cell Biochem. 1996;163:223–9. PubMedCrossRef
3.
Zurück zum Zitat Bengtsson BA, Christiansen JS, Cuneo RC, Sacca L. Cardiovascular effects of GH. J Endocrinol. 1997;152:1–3. PubMedCrossRef Bengtsson BA, Christiansen JS, Cuneo RC, Sacca L. Cardiovascular effects of GH. J Endocrinol. 1997;152:1–3. PubMedCrossRef
4.
5.
Zurück zum Zitat Lombardini G, Colao A, Marzullo P, et al. Is growth hormone bad for your heart: cardiovascular impact of GH deficiency and excess. J Endocrinol. 1997;155:S33–7. Lombardini G, Colao A, Marzullo P, et al. Is growth hormone bad for your heart: cardiovascular impact of GH deficiency and excess. J Endocrinol. 1997;155:S33–7.
6.
Zurück zum Zitat Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 1993;129:195–200. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 1993;129:195–200.
7.
Zurück zum Zitat Merola B, Cittadini A, Colao A, et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab. 1993;77:1658–61. PubMed Merola B, Cittadini A, Colao A, et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab. 1993;77:1658–61. PubMed
8.
Zurück zum Zitat Longobardi S, Cuocolo A, Merola B, et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol. 1998;48:137–43. CrossRef Longobardi S, Cuocolo A, Merola B, et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol. 1998;48:137–43. CrossRef
9.
Zurück zum Zitat Colao A, Cuocolo A, Di Somma C, et al. Impaired cardiac performance in elderly patients with growth hormone deficiency. J Clin Endocrinol Metab. 1999;84:3950–5. PubMedCrossRef Colao A, Cuocolo A, Di Somma C, et al. Impaired cardiac performance in elderly patients with growth hormone deficiency. J Clin Endocrinol Metab. 1999;84:3950–5. PubMedCrossRef
10.
Zurück zum Zitat Capaldo B, Patti L, Oliviero U, et al. Increased arterial intima-media thickness in childhood onset growth hormone deficiency. J Clin Endocrinol Metab. 1997;82:1378–81. PubMedCrossRef Capaldo B, Patti L, Oliviero U, et al. Increased arterial intima-media thickness in childhood onset growth hormone deficiency. J Clin Endocrinol Metab. 1997;82:1378–81. PubMedCrossRef
11.
Zurück zum Zitat Pfeifer M, Verhovec R, Zizek B. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab. 1999;84:453–7. PubMed Pfeifer M, Verhovec R, Zizek B. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab. 1999;84:453–7. PubMed
12.
Zurück zum Zitat Ter Maaten JC, De Boer H, Kamp O, et al. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab. 1999;84:2373–80. Ter Maaten JC, De Boer H, Kamp O, et al. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab. 1999;84:2373–80.
13.
Zurück zum Zitat Vacaldi R, Gaddi O, Zini M, et al. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab. 1995;80:659–66. Vacaldi R, Gaddi O, Zini M, et al. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab. 1995;80:659–66.
14.
Zurück zum Zitat Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:1621–34. PubMedCrossRef Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:1621–34. PubMedCrossRef
15.
Zurück zum Zitat Dumesnil JG, Dion D, Yvorchuk K, et al. A new, simple and accurate method for determining ejection fraction by Doppler echocardiography. Can J Cardiol. 1995;11:1007–14. PubMed Dumesnil JG, Dion D, Yvorchuk K, et al. A new, simple and accurate method for determining ejection fraction by Doppler echocardiography. Can J Cardiol. 1995;11:1007–14. PubMed
16.
Zurück zum Zitat Colao A, Di Somma C, Cuocolo A, et al. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency. J Clin Endocrinol Metab. 2005;90:5146–55. PubMedCrossRef Colao A, Di Somma C, Cuocolo A, et al. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency. J Clin Endocrinol Metab. 2005;90:5146–55. PubMedCrossRef
17.
Zurück zum Zitat Attanasio AF, Lamberts SW, Matranga AM, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab. 1997;82:82–8. PubMed Attanasio AF, Lamberts SW, Matranga AM, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab. 1997;82:82–8. PubMed
18.
Zurück zum Zitat Burger AG, Monson JP, Colao AM, et al. Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution. Endocr Pract. 2006;12:682–9. PubMedCrossRef Burger AG, Monson JP, Colao AM, et al. Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution. Endocr Pract. 2006;12:682–9. PubMedCrossRef
19.
Zurück zum Zitat Colao A, di Somma C, Cuocolo A, et al. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab. 2001;86:1874–81. PubMed Colao A, di Somma C, Cuocolo A, et al. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab. 2001;86:1874–81. PubMed
20.
Zurück zum Zitat Minczykowski A, Gryczynska M, Ziemnicka K, et al. The influence of growth hormonetherapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency. Int J Cardiol. 2005;101:257–63. PubMedCrossRef Minczykowski A, Gryczynska M, Ziemnicka K, et al. The influence of growth hormonetherapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency. Int J Cardiol. 2005;101:257–63. PubMedCrossRef
21.
Zurück zum Zitat Amato G, Mazziotti G, di Somma C, et al. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endocrinol Metab. 2000;85:3720–5. PubMedCrossRef Amato G, Mazziotti G, di Somma C, et al. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endocrinol Metab. 2000;85:3720–5. PubMedCrossRef
22.
Zurück zum Zitat Cho GY, Jeong IK, Kim SH, et al. Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency. Am J Cardiol. 2007;100:1035–9. PubMedCrossRef Cho GY, Jeong IK, Kim SH, et al. Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency. Am J Cardiol. 2007;100:1035–9. PubMedCrossRef
Metadaten
Titel
The effect of growth hormone replacement therapy on the morphological and functional changes in the left ventricle in patients with adult-onset growth hormone deficiency
verfasst von
MD, PhD Anton Dlesk
MD, PhD Assoc. Prof. Gabriel Kamenský
MD, PhD Prof. Ivica Lazúrová
MD, PhD Martin Kužma
MD, PhD Prof. Juraj Payer
Publikationsdatum
01.08.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 15-16/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0536-2